Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
NeuroPace Inc. (NPCE) Insider Trading Activity
Healthcare • Medical Devices • 179 employees
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Total Value
-$52,477,324.14
Total Shares
-5,649,033
Average Trade Value
-$1,590,221.94
Most Active Insider
Kck Ltd.
Total Activity: $51,086,516
Largest Single Transaction
$49,545,943
by Kck Ltd. on Feb 20, 2025
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Chief Financial Officer
|
Mar 3, 2025 | 1,337 | $15,790 | 124,895 (-1.1%) | Payment of Exercise Price | |
|
Chief Medical Officer
|
Mar 3, 2025 | 1,337 | $15,790 | 79,226 (-1.7%) | Payment of Exercise Price | |
|
Chief Financial Officer
|
Feb 27, 2025 | 1,430 | $17,961 | 126,232 (-1.1%) | Payment of Exercise Price | |
|
Chief Medical Officer
|
Feb 27, 2025 | 1,430 | $17,961 | 80,563 (-1.8%) | Payment of Exercise Price | |
|
Chief Medical Officer
|
Feb 21, 2025 | 78,334 | $1,074,844 | 81,993 (-95.5%) | Sale | |
|
Chief Financial Officer
|
Feb 20, 2025 | 3,405 | $48,453 | 127,662 (-2.7%) | Payment of Exercise Price | |
|
Chief Medical Officer
|
Feb 20, 2025 | 3,405 | $48,453 | 43,670 (-7.8%) | Payment of Exercise Price | |
|
10% Owner
|
Feb 20, 2025 | 5,270,845 | $49,545,943 | 0 | Sale | |
|
Chief Medical Officer
|
Jan 30, 2025 | 200 | $3,000 | 86,762 (-0.2%) | Sale | |
|
Chief Medical Officer
|
Jan 29, 2025 | 100 | $1,500 | 86,962 (-0.1%) | Sale | |
|
Chief Medical Officer
|
Jan 24, 2025 | 3,200 | $48,032 | 87,062 (-3.7%) | Sale | |
|
Chief Financial Officer
|
Jan 22, 2025 | 265 | $3,721 | 118,129 (-0.2%) | Payment of Exercise Price | |
|
Chief Medical Officer
|
Jan 22, 2025 | 265 | $3,721 | 47,075 (-0.6%) | Payment of Exercise Price | |
|
Chief Medical Officer
|
Dec 3, 2024 | 1,413 | $16,857 | 47,340 (-3.0%) | Payment of Exercise Price | |
|
Chief Financial Officer
|
Dec 3, 2024 | 1,334 | $15,915 | 118,394 (-1.1%) | Payment of Exercise Price | |
|
Chief Financial Officer
|
Nov 20, 2024 | 3,045 | $27,984 | 119,728 (-2.5%) | Payment of Exercise Price | |
|
Chief Medical Officer
|
Nov 20, 2024 | 3,045 | $27,984 | 48,753 (-6.2%) | Payment of Exercise Price | |
|
10% Owner
|
Oct 25, 2024 | 223,991 | $1,221,042 | 5,270,845 (-4.2%) | Sale | |
|
10% Owner
|
Oct 23, 2024 | 147 | $885 | 5,494,836 (-0.0%) | Sale | |
|
10% Owner
|
Oct 22, 2024 | 4,082 | $24,853 | 5,494,983 (-0.1%) | Sale | |
|
Chief Financial Officer
|
Oct 22, 2024 | 237 | $1,422 | 122,773 (-0.2%) | Payment of Exercise Price | |
|
Chief Medical Officer
|
Oct 22, 2024 | 237 | $1,422 | 51,798 (-0.5%) | Payment of Exercise Price | |
|
10% Owner
|
Oct 21, 2024 | 3,720 | $22,679 | 5,499,065 (-0.1%) | Sale | |
|
10% Owner
|
Oct 18, 2024 | 4,878 | $30,692 | 5,502,785 (-0.1%) | Sale | |
|
10% Owner
|
Oct 17, 2024 | 3,294 | $20,686 | 5,507,663 (-0.1%) | Sale | |
|
10% Owner
|
Oct 16, 2024 | 6,900 | $45,336 | 5,510,957 (-0.1%) | Sale | |
|
10% Owner
|
Oct 15, 2024 | 4,017 | $26,098 | 5,517,857 (-0.1%) | Sale | |
|
10% Owner
|
Oct 14, 2024 | 4,031 | $26,360 | 5,521,874 (-0.1%) | Sale | |
|
10% Owner
|
Oct 11, 2024 | 2,572 | $16,320 | 5,525,905 (-0.0%) | Sale | |
|
10% Owner
|
Oct 10, 2024 | 2,504 | $15,317 | 5,528,477 (-0.0%) | Sale | |
|
10% Owner
|
Oct 9, 2024 | 3,123 | $19,065 | 5,530,981 (-0.1%) | Sale | |
|
10% Owner
|
Oct 8, 2024 | 6,000 | $38,552 | 5,534,104 (-0.1%) | Sale | |
|
10% Owner
|
Oct 7, 2024 | 4,910 | $32,687 | 5,540,104 (-0.1%) | Sale |